The impact of structural uncertainty on cost effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease specific model standardization and improved guidance

MLA

Frederix, GWJ (Geert), et al. “The Impact of Structural Uncertainty on Cost Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: The Need for Disease Specific Model Standardization and Improved Guidance.” Frederix , GWJ , van Hasselt , JGC , Schellens , JHM , Hovels , AM , Raaijmakers , JAM , Huitema , ADR & Severens , H 2014 , ’ The Impact of Structural Uncertainty on Cost Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: The Need for Disease Specific Model Standardization and Improved Guidance ’ , Pharmacoeconomics (Print) , Pp. 47-61 , 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313618261&authtype=sso&custid=ns315887.

APA

Frederix, G. (Geert), van Hasselt, J., Schellens, J. (Jan), Hovels, A., Raaijmakers, J., Huitema, A., & Severens, H. (2014). The impact of structural uncertainty on cost effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease specific model standardization and improved guidance. Frederix , GWJ , van Hasselt , JGC , Schellens , JHM , Hovels , AM , Raaijmakers , JAM , Huitema , ADR & Severens , H 2014 , ’ The Impact of Structural Uncertainty on Cost Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: The Need for Disease Specific Model Standardization and Improved Guidance ’ , Pharmacoeconomics (Print) , Pp. 47-61 .

Chicago

Frederix, GWJ (Geert), Jgc van Hasselt, JHM (Jan) Schellens, Am Hovels, Jam Raaijmakers, Adr Huitema, and Hans Severens. 2014. “The Impact of Structural Uncertainty on Cost Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: The Need for Disease Specific Model Standardization and Improved Guidance.” Frederix , GWJ , van Hasselt , JGC , Schellens , JHM , Hovels , AM , Raaijmakers , JAM , Huitema , ADR & Severens , H 2014 , ’ The Impact of Structural Uncertainty on Cost Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: The Need for Disease Specific Model Standardization and Improved Guidance ’ , Pharmacoeconomics (Print) , Pp. 47-61 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313618261&authtype=sso&custid=ns315887.